The forecast for Capital Health Expenditure in Brazil shows a consistent decline from 0.31% of GDP in 2024 to 0.27% in 2028. Compared to the actual data from 2023, this indicates a year-on-year decrease of approximately 3.23% in 2025, followed by similar annual reductions of around 3.33% in subsequent years. The Compound Annual Growth Rate (CAGR) for the period 2024-2028 indicates an average yearly decline of about 3.33%.
Future trends to watch include potential government policy changes, economic conditions affecting GDP, and technological advancements in healthcare. These factors could alter the forecast and necessitate adjustments in capital expenditure strategies.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...